Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN study
(1)
,
(2)
,
(3)
,
(4)
,
(5)
,
(6)
,
(7)
,
(8)
,
(9)
,
(10)
,
(10)
,
(10)
,
(10)
,
(10)
1
2
3
4
5
6
7
8
9
10
2
3
4
5
6
7
8
9
10